Main menu button

Carlsquare advised on Bifodan's sale to Deerland Probiotics & Enzymes

Carlsquare advised the shareholders of Bifodan in relation to a sale and partial reinvestment into Deerland Probiotics & Enzymes, a platform investment of US-based Roundtable Healthcare Partners.

Bent Andersen, Chairman of Bifodan:
“We are very happy that we have come to an agreement on creating a global player within probiotic dietary food supplements. The transaction offered the investors an opportunity to realize their shares at attractive terms, while at the same time allowing flexibility to reinvest into the acquiring company in order to benefit from the synergies and future value creation of the combined entities.
Given the complexity of the transaction, involving multiple work streams, we are very satisfied that we had a strong team of dedicated financial and legal advisors that worked well together to make this happen.”

Bifodan A/S develops and manufactures probiotic turnkey solutions for private label customers worldwide. Bifodan delivers clinically documented, high-quality probiotic products, manufactured at a GMP approved production facility. Bifodan has been dedicated to the research and development of probiotic nutritional supplements since 1992 and currently covers four segments: Digestion, Immune Health, Women’s Health and Oral Health.

Bifodan has a long history in probiotic bacteria, as the company was founded by the first Danish dairy to isolate the lactobacillus acidophilus bacteria in 1938. The company is headquartered in Denmark and has sales offices in the USA, the Netherlands, the Czech Republic, Italy and China.

Deerland Probiotics & Enzymes, USA, specializes in developing science-backed solutions that benefit microbiome health, using probiotic, prebiotic and enzyme technology. The company offers a line of unique, clinically supported branded products, including DE111®, PreforPro®, ProHydrolase®, Solarplast® and Glutalytic®.

Deerland collaborates with customers to develop innovative and often proprietary solutions in the dietary supplement and food and beverage markets. In addition to branded ingredients and customized formulations, Deerland offers full turn key manufacturing services.

Deerland Probiotics & Enzymes is a platform investment of RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry.

Carlsquare acted as financial advisor to the shareholders of Bifodan.

Client: Bifodan A/S
Industry: Life Science
Assignment: Sellside
Bifodan A/S
Deerland Probiotics & Enzymes
Anders Bo
Anders Bo LinkedIn
Managing Partner